Search research articles
Contact Us
Filters
Showing results (51-60 of 145) with videos related to
Page
of 15
Sort By:
Gynecologic Oncology
|
October 23, 2025
Survival impact of residual disease and timing of surgery in the management of advanced-stage low grade serous ovarian cancer: A systematic review and meta-analysis
Judicael Hotton, Thomas Gaillard, Xavier Paoletti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 3, 2006
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding study
Xavier Paoletti, Benoît Baron, Patrick Schöffski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium
Francisco Bautista, Lucas Moreno, Lynley Marshall, et al.
The Oncologist
|
December 28, 2014
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma
Momar Diouf, Franck Bonnetain, Jean-Claude Barbare, et al.
Chinese Clinical Oncology
|
September 27, 2015
Design and statistical principles of the SHIVA trial
Xavier Paoletti, Bernard Asselain, Maud Kamal, et al.
Biological Psychiatry
|
January 30, 2010
Impaired smooth pursuit in schizophrenia results from prediction impairment only
Irene Nkam, Marie-Laure Bocca, Pierre Denise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2013
Critical evaluation of disease stabilization as a measure of activity of systemic therapy: lessons from trials with arms in which patients do not receive active treatment
Christophe Le Tourneau, Xavier Paoletti, Elodie Coquan, et al.
Biometrical Journal. Biometrische Zeitschrift
|
February 17, 2015
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
Marc Buyse, Geert Molenberghs, Xavier Paoletti, et al.
Pharmacology & Therapeutics
|
March 5, 2019
Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity
Ali N Chamseddine, Michel Ducreux, Jean-Pierre Armand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2020
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research
Cyrus Chargari, Antonin Levy, Xavier Paoletti, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 145) with videos related to
Sort By:
Page
of 15
Gynecologic Oncology
|
October 23, 2025
Survival impact of residual disease and timing of surgery in the management of advanced-stage low grade serous ovarian cancer: A systematic review and meta-analysis
Judicael Hotton, Thomas Gaillard, Xavier Paoletti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 3, 2006
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding study
Xavier Paoletti, Benoît Baron, Patrick Schöffski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium
Francisco Bautista, Lucas Moreno, Lynley Marshall, et al.
The Oncologist
|
December 28, 2014
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma
Momar Diouf, Franck Bonnetain, Jean-Claude Barbare, et al.
Chinese Clinical Oncology
|
September 27, 2015
Design and statistical principles of the SHIVA trial
Xavier Paoletti, Bernard Asselain, Maud Kamal, et al.
Biological Psychiatry
|
January 30, 2010
Impaired smooth pursuit in schizophrenia results from prediction impairment only
Irene Nkam, Marie-Laure Bocca, Pierre Denise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2013
Critical evaluation of disease stabilization as a measure of activity of systemic therapy: lessons from trials with arms in which patients do not receive active treatment
Christophe Le Tourneau, Xavier Paoletti, Elodie Coquan, et al.
Biometrical Journal. Biometrische Zeitschrift
|
February 17, 2015
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
Marc Buyse, Geert Molenberghs, Xavier Paoletti, et al.
Pharmacology & Therapeutics
|
March 5, 2019
Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity
Ali N Chamseddine, Michel Ducreux, Jean-Pierre Armand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2020
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research
Cyrus Chargari, Antonin Levy, Xavier Paoletti, et al.
Page
of 15